贤丰控股(002141) - 2024 Q4 - 年度业绩预告

Financial Projections - The estimated net profit for 2024 is projected to be a loss between 94 million to 115 million RMB, a decrease of 4.26% to 21.74% compared to the previous year's loss of 120.12 million RMB[4]. - Total profit is expected to be a loss between 105 million to 136 million RMB, which is a reduction of 0.78% to 23.40% from the previous year's loss of 137.07 million RMB[5]. - The estimated operating revenue is projected to be between 350 million to 455 million RMB, with a net operating revenue after deductions expected to be between 340 million to 440 million RMB[6]. Revenue and Business Performance - The significant revenue change is attributed to the new copper-clad laminate and animal nutrition (feed) business, while losses are primarily due to underperformance in the veterinary vaccine business and related goodwill impairment provisions[8]. Risk Factors - The company faces a risk of delisting if the audited total profit, net profit, and net profit after deducting non-recurring gains and losses are all negative, and if the operating revenue after deductions is below 300 million RMB[9]. Internal Control and Compliance - The company has completed rectification of internal control deficiencies related to the negative opinion in the 2023 internal control audit report, and plans to apply for the removal of risk warnings if the 2024 internal control audit report is unqualified[10].